Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, DOSE, BAP-65
M. Gayaf (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), F. Güldaval (Izmir, Turkey), G. Polat (Izmir, Turkey), M. Türk (Izmir, Turkey)
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Session: Monitoring of patients with COPD
Session type: E-poster session
Number: 1048
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gayaf (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), F. Güldaval (Izmir, Turkey), G. Polat (Izmir, Turkey), M. Türk (Izmir, Turkey). Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, DOSE, BAP-65. 1048
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Commutity acquired pneumonia scores utility. PSI (FINE) vs BTSm (CURB) Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
Comparison of PSI, A-DROP, CURB-65, CRB-65, and SOAR indices in hospitalized patients with community acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD) Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015
Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Source: Eur Respir J 2008; 31: 349-355 Year: 2008
Prognostic value of the pneumonia severity index (PSI), CURB-65 for young and elderly patients Source: Annual Congress 2009 - Pulmonary infections Year: 2009
Predicting in-hospital death in pneumonic COPD exacerbation via BAP-65, CURB-65 and machine learning Source: ERJ Open Res, 8 (1) 00452-2021; 10.1183/23120541.00452-2021 Year: 2022
eCURB outperforms CURB-65 and A-DROP for predicting 30-day mortality in pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
The index distance-saturation product like predicting of mortality in patients with COPD Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment Year: 2008
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015
Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1 Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Mortality predictions of CURB-65, GPS and CALL scores in hospitalized patients with COVID-19 Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021
A simplified BODE score to predict mortality in patients with COPD: the role of 4-min step test Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014
A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Evaluation of sequential organ failure assessment (SOFA) based models for predicting mortality in ICU patients Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Usefulness of CURB-65, PSI and MuLBSTA in predicting COVID-19 mortality Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021